{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:38:18Z","timestamp":1785825498398,"version":"3.56.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6-7","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genet"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Identifying genetic risk factors for parasitic infections such as the leishmaniases could provide important leads for improved therapies and vaccines. Until recently most genetic studies of human leishmaniasis were underpowered and\/or not replicated. Here, we focus on recent genome-wide association studies of visceral leishmaniasis (VL) and cutaneous leishmaniasis (CL). For VL, analysis across 2287 cases and 2692 controls from three cohorts identified a single major peak of genome-wide significance (<jats:italic>P<\/jats:italic><jats:sub>combined<\/jats:sub>\u2009=\u20092.76\u2009\u00d7\u200910<jats:sup>\u201317<\/jats:sup>) at <jats:italic>HLA-DRB1<\/jats:italic>\u2013<jats:italic>HLA-DQA1<\/jats:italic>. HLA-DRB1*1501 and DRB1*1404\/DRB1*1301 were the most significant protective versus risk alleles, respectively, with specific residues at amino acid positions 11 and 13 unique to protective alleles. Epitope-binding studies showed higher frequency of basic AAs in DRB1*1404-\/*1301-specific epitopes compared to hydrophobic and polar AAs in DRB1*1501-specific epitopes at anchor residues P4 and P6 which interact with residues at DRB1 positions 11 and 13. For CL, genome-wide significance was not achieved in combined analysis of 2066 cases and 2046 controls across 2 cohorts. Rather, multiple top hits at <jats:italic>P<\/jats:italic>\u2009&lt;\u20095\u2009\u00d7\u200910<jats:sup>\u20135<\/jats:sup> were observed, amongst which <jats:italic>IFNG-AS1<\/jats:italic> was of specific interest as a non-coding anti-sense RNA known to influence responses to pathogens by increasing IFN-\u03b3 secretion. Association at <jats:italic>LAMP3<\/jats:italic> encoding dendritic cell lysosomal associated membrane protein 3 was also interesting. LAMP3 increases markedly upon activation of dendritic cells, localizing to the MHC Class II compartment immediately prior to translocation of Class II to the cell surface. Together these GWAS results provide firm confirmation for the importance of antigen presentation and the regulation of IFN\u03b3 in determining the outcome of <jats:italic>Leishmania<\/jats:italic> infections.<\/jats:p>","DOI":"10.1007\/s00439-020-02130-w","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T14:02:41Z","timestamp":1581602561000},"page":"813-819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Human genetics of leishmania infections"],"prefix":"10.1007","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0784-7277","authenticated-orcid":false,"given":"Jenefer M.","family":"Blackwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Fakiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a C.","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"2130_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.coi.2014.07.002","volume":"30C","author":"L Abel","year":"2014","unstructured":"Abel L, Alcais A, Schurr E (2014) The dissection of complex susceptibility to infectious disease: bacterial, viral and parasitic infections. Curr Opin Immunol 30C:72\u201378. https:\/\/doi.org\/10.1016\/j.coi.2014.07.002","journal-title":"Curr Opin Immunol"},{"key":"2130_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.meegid.2014.12.034","volume":"30","author":"L Almeida","year":"2015","unstructured":"Almeida L, Oliveira J, Guimaraes LH, Carvalho EM, Blackwell JM, Castellucci L (2015) Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil: role of COL1A1. Infect Genet Evol 30:225\u2013229. https:\/\/doi.org\/10.1016\/j.meegid.2014.12.034","journal-title":"Infect Genet Evol"},{"key":"2130_CR3","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 7:e35671. https:\/\/doi.org\/10.1371\/journal.pone.0035671","journal-title":"PLoS ONE"},{"key":"2130_CR4","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1128\/IAI.70.12.6734-6740.2002","volume":"70","author":"O Bacellar","year":"2002","unstructured":"Bacellar O, Lessa H, Schriefer A, Machado P, Ribeiro de Jesus A, Dutra WO, Gollob KJ, Carvalho EM (2002) Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 70:6734\u20136740","journal-title":"Infect Immun"},{"key":"2130_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/infdis\/154.4.639","volume":"154","author":"R Badaro","year":"1986","unstructured":"Badaro R, Jones TC, Lorenco R, Cerf BJ, Sampaio D, Carvalho EM, Rocha H, Teixeira R, Johnson WD Jr (1986) A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 154:639\u2013649","journal-title":"J Infect Dis"},{"key":"2130_CR6","first-page":"483","volume-title":"Immunology of infectious diseases","author":"JM Blackwell","year":"2010","unstructured":"Blackwell JM (2010) Chapter 35: Immunogenetics of host response to parasites in humans. In: Kaufmann SHE, Rouse B, Sacks D (eds) Immunology of infectious diseases. ASM Publications, Washington, pp 483\u2013490"},{"key":"2130_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1128\/CMR.00048-08","volume":"22","author":"JM Blackwell","year":"2009","unstructured":"Blackwell JM, Jamieson SE, Burgner D (2009) HLA and infectious diseases. Clin Microbiol Rev 22:370\u2013385","journal-title":"Clin Microbiol Rev"},{"key":"2130_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.gene.6364355","volume":"8","author":"B Bucheton","year":"2007","unstructured":"Bucheton B, Argiro L, Chevillard C, Marquet S, Kheir MM, Mergani A, El-Safi SH, Dessein AJ (2007) Identification of a novel G245R polymorphism in the IL-2 receptor beta membrane proximal domain associated with human visceral leishmaniasis. Genes Immun 8:79\u201383","journal-title":"Genes Immun"},{"key":"2130_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1473-3099(06)70601-6","volume":"6","author":"D Burgner","year":"2006","unstructured":"Burgner D, Jamieson SE, Blackwell JM (2006) Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? Lancet Infect Dis 6:653\u2013663","journal-title":"Lancet Infect Dis"},{"key":"2130_CR10","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1084\/jem.182.5.1259","volume":"182","author":"M Cabrera","year":"1995","unstructured":"Cabrera M, Shaw M-A, Sharples C, Williams H, Castes M, Convit J, Blackwell JM (1995) Polymorphism in TNF genes associated with mucocutaneous leishmaniasis. J Exp Med 182:1259\u20131264","journal-title":"J Exp Med"},{"key":"2130_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1086\/505504","volume":"194","author":"L Castellucci","year":"2006","unstructured":"Castellucci L, Menezes E, Oliveira J, Magalhaes A, Guimaraes LH, Lessa M, Ribeiro S, Reale J, Noronha EF, Wilson ME, Duggal P, Beaty TH, Jeronimo S, Jamieson SE, Bales A, Blackwell JM, de Jesus AR, Carvalho EM (2006) IL6 -174 G\/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J Infect Dis 194:519\u2013527","journal-title":"J Infect Dis"},{"key":"2130_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2350-11-10","volume":"11","author":"L Castellucci","year":"2010","unstructured":"Castellucci L, Jamieson SE, Miller EN, Menezes E, Oliveira J, Magalhaes A, Guimaraes LH, Lessa M, de Jesus AR, Carvalho EM, Blackwell JM (2010) CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study. BMC Med Genet 11:10","journal-title":"BMC Med Genet"},{"key":"2130_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/gene.2011.37","volume":"12","author":"L Castellucci","year":"2011","unstructured":"Castellucci L, Jamieson SE, Miller EN, de Almeida LF, Oliveira J, Magalhaes A, Guimaraes LH, Lessa M, Lago E, de Jesus AR, Carvalho EM, Blackwell JM (2011) FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil. Genes Immun 12:589\u2013594. https:\/\/doi.org\/10.1038\/gene.2011.37","journal-title":"Genes Immun"},{"key":"2130_CR14","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.meegid.2012.03.017","volume":"12","author":"L Castellucci","year":"2012","unstructured":"Castellucci L, Jamieson SE, Almeida L, Oliveira J, Guimaraes LH, Lessa M, Fakiola M, Jesus AR, Nancy Miller E, Carvalho EM, Blackwell JM (2012) Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil. Infect Genet Evol 12:1102\u20131110. https:\/\/doi.org\/10.1016\/j.meegid.2012.03.017","journal-title":"Infect Genet Evol"},{"key":"2130_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1590\/0074-0276140028","volume":"109","author":"LC Castellucci","year":"2014","unstructured":"Castellucci LC, Almeida LF, Jamieson SE, Fakiola M, Carvalho EM, Blackwell JM (2014) Host genetic factors in American cutaneous leishmaniasis: a critical appraisal of studies conducted in an endemic area of Brazil. Mem Inst Oswaldo Cruz 109:279\u2013288","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2130_CR16","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.13.903989","author":"LC Castellucci","year":"2020","unstructured":"Castellucci LC, Almeida L, Cherllin S, Fakiola M, Carvalho E, Figueriedo AB, Cavalcanti CM, Alves NS, Gollob KJ, Dutra WO, Cordell HJ, Blackwell JM (2020) A genome-wide association study highlights a regulatory role for IFNG-AS1 contributing to cutaneous leishmaniasis in Brazil. J Infect Dis 10.1101\/2020.01.13.903989","journal-title":"J Infect Dis"},{"key":"2130_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-3024.1989.tb00660.x","volume":"11","author":"M Castes","year":"1989","unstructured":"Castes M, Moros Z, Martinez A, Trujillo D, Castellanos PL, Rondon AJ, Convit J (1989) Cell-mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapy. Parasite Immunol 11:211\u2013222","journal-title":"Parasite Immunol"},{"key":"2130_CR18","first-page":"233","volume":"26","author":"M Castes","year":"1993","unstructured":"Castes M, Trujillo D, Rojas ME, Fernandez CT, Araya L, Cabrera M, Blackwell J, Convit J (1993) Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Biol Res 26:233\u2013238","journal-title":"Biol Res"},{"key":"2130_CR19","doi-asserted-by":"publisher","first-page":"e0007216","DOI":"10.1371\/journal.pntd.0007216","volume":"13","author":"J Chakravarty","year":"2019","unstructured":"Chakravarty J, Hasker E, Kansal S, Singh OP, Malaviya P, Singh AK, Chourasia A, Singh T, Sudarshan M, Singh AP, Singh B, Singh RP, Ostyn B, Fakiola M, Picado A, Menten J, Blackwell JM, Wilson ME, Sacks D, Boelaert M, Sundar S (2019) Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: a cohort study. PLoS Negl Trop Dis 13:e0007216. https:\/\/doi.org\/10.1371\/journal.pntd.0007216","journal-title":"PLoS Negl Trop Dis"},{"key":"2130_CR20","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.4049\/jimmunol.1200774","volume":"189","author":"SP Collier","year":"2012","unstructured":"Collier SP, Collins PL, Williams CL, Boothby MR, Aune TM (2012) Cutting edge: influence of Tmevpg1, a long intergenic noncoding RNA, on the expression of Ifng by Th1 cells. J Immunol 189:2084\u20132088. https:\/\/doi.org\/10.4049\/jimmunol.1200774","journal-title":"J Immunol"},{"key":"2130_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/s1074-7613(00)80615-9","volume":"9","author":"B de Saint-Vis","year":"1998","unstructured":"de Saint-Vis B, Vincent J, Vandenabeele S, Vanbervliet B, Pin JJ, Ait-Yahia S, Patel S, Mattei MG, Banchereau J, Zurawski S, Davoust J, Caux C, Lebecque S (1998) A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9:325\u2013336. https:\/\/doi.org\/10.1016\/s1074-7613(00)80615-9","journal-title":"Immunity"},{"key":"2130_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1590\/S0037-86822002000100002","volume":"35","author":"A D'Oliveira Jr","year":"2002","unstructured":"D'Oliveira A Jr, Machado P, Bacellar O, Cheng LH, Almeida RP, Carvalho EM (2002) Evaluation of IFN-gamma and TNF-alpha as immunological markers of clinical outcome in cutaneous leishmaniasis. Rev Soc Bras Med Trop 35:7\u201310","journal-title":"Rev Soc Bras Med Trop"},{"key":"2130_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/gepi.20297","volume":"32","author":"F Dudbridge","year":"2008","unstructured":"Dudbridge F, Gusnanto A (2008) Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 32:227\u2013234. https:\/\/doi.org\/10.1002\/gepi.20297","journal-title":"Genet Epidemiol"},{"key":"2130_CR24","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/ejhg.2015.269","volume":"24","author":"J Fadista","year":"2016","unstructured":"Fadista J, Manning AK, Florez JC, Groop L (2016) The (in)famous GWAS P-value threshold revisited and updated for low-frequency variants. Eur J Hum Genet 24:1202\u20131205. https:\/\/doi.org\/10.1038\/ejhg.2015.269","journal-title":"Eur J Hum Genet"},{"key":"2130_CR25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/infdis\/jir284","volume":"204","author":"M Fakiola","year":"2011","unstructured":"Fakiola M, Miller EN, Fadl M, Mohamed HS, Jamieson SE, Francis RW, Cordell HJ, Peacock CS, Raju M, Khalil EA, Elhassan A, Musa AM, Silveira F, Shaw JJ, Sundar S, Jeronimo SM, Ibrahim ME, Blackwell JM (2011) Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27. J Infect Dis 204:467\u2013477. https:\/\/doi.org\/10.1093\/infdis\/jir284","journal-title":"J Infect Dis"},{"key":"2130_CR26","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/ng.2518","volume":"45","author":"M Fakiola","year":"2013","unstructured":"Fakiola M, Strange A, Cordell HJ, Miller EN, Pirinen M, Su Z, Mishra A, Mehrotra S, Monteiro GR, Band G, Bellenguez C, Dronov S, Edkins S, Freeman C, Giannoulatou E, Gray E, Hunt SE, Lacerda HG, Langford C, Pearson R, Pontes NN, Rai M, Singh SP, Smith L, Sousa O, Vukcevic D, Bramon E, Brown MA, Casas JP, Corvin A, Duncanson A, Jankowski J, Markus HS, Mathew CG, Palmer CN, Plomin R, Rautanen A, Sawcer SJ, Trembath RC, Viswanathan AC, Wood NW, Wilson ME, Deloukas P, Peltonen L, Christiansen F, Witt C, Jeronimo SM, Sundar S, Spencer CC, Blackwell JM, Donnelly P (2013) Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. Nat Genet 45:208\u2013213. https:\/\/doi.org\/10.1038\/ng.2518","journal-title":"Nat Genet"},{"key":"2130_CR27","doi-asserted-by":"publisher","first-page":"7853","DOI":"10.1128\/IAI.73.12.7853-7859.2005","volume":"73","author":"DR Faria","year":"2005","unstructured":"Faria DR, Gollob KJ, Barbosa J Jr, Schriefer A, Machado PR, Lessa H, Carvalho LP, Romano-Silva MA, de Jesus AR, Carvalho EM, Dutra WO (2005a) Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 73:7853\u20137859. https:\/\/doi.org\/10.1128\/IAI.73.12.7853-7859.2005","journal-title":"Infect Immun"},{"key":"2130_CR28","doi-asserted-by":"publisher","first-page":"7853","DOI":"10.1128\/IAI.73.12.7853-7859.2005","volume":"73","author":"DR Faria","year":"2005","unstructured":"Faria DR, Gollob KJ, Barbosa JJ, Schriefer A, Machado PR, Lessa H, Carvalho LP, Romano-Silva MA, De Jesus AR, Carvalho EM, Dutra WO (2005b) Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 73:7853\u20137859","journal-title":"Infect Immun"},{"key":"2130_CR29","doi-asserted-by":"publisher","first-page":"E54","DOI":"10.1086\/340261","volume":"34","author":"I Follador","year":"2002","unstructured":"Follador I, Araujo C, Bacellar O, Araujo CB, Carvalho LP, Almeida RP, Carvalho EM (2002) Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection. Clin Infect Dis 34:E54\u2013E58","journal-title":"Clin Infect Dis"},{"key":"2130_CR30","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/infdis\/jir461","volume":"204","author":"S Gautam","year":"2011","unstructured":"Gautam S, Kumar R, Maurya R, Nylen S, Ansari N, Rai M, Sundar S, Sacks D (2011) IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J Infect Dis 204:1134\u20131137. https:\/\/doi.org\/10.1093\/infdis\/jir461","journal-title":"J Infect Dis"},{"key":"2130_CR31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1365-2249.2007.03436.x","volume":"149","author":"A Gomes-Silva","year":"2007","unstructured":"Gomes-Silva A, de Cassia BR, Dos Santos NR, Amato VS, da Silva MM, Oliveira-Neto MP, Coutinho SG, Da-Cruz AM (2007) Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? Clin Exp Immunol 149:440\u2013444. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03436.x","journal-title":"Clin Exp Immunol"},{"key":"2130_CR32","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.cell.2013.01.015","volume":"152","author":"JA Gomez","year":"2013","unstructured":"Gomez JA, Wapinski OL, Yang YW, Bureau JF, Gopinath S, Monack DM, Chang HY, Brahic M, Kirkegaard K (2013) The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-gamma locus. Cell 152:743\u2013754. https:\/\/doi.org\/10.1016\/j.cell.2013.01.015","journal-title":"Cell"},{"key":"2130_CR33","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.4269\/ajtmh.18-0448","volume":"99","author":"E Hasker","year":"2018","unstructured":"Hasker E, Malaviya P, Cloots K, Picado A, Singh OP, Kansal S, Boelaert M, Sundar S (2018) Visceral Leishmaniasis in the Muzaffapur Demographic Surveillance Site: A Spatiotemporal Analysis. Am J Trop Med Hyg 99:1555\u20131561. https:\/\/doi.org\/10.4269\/ajtmh.18-0448","journal-title":"Am J Trop Med Hyg"},{"key":"2130_CR34","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/0035-9203(82)90095-5","volume":"76","author":"M Ho","year":"1982","unstructured":"Ho M, Siongok TK, Lyerly WH, Smith DH (1982) Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya. Trans R Soc Trop Med Hyg 76:741\u2013746","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2130_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/sj.gene.6364357","volume":"8","author":"SE Jamieson","year":"2007","unstructured":"Jamieson SE, Miller EN, Peacock CS, Fakiola M, Wilson ME, Bales-Holst A, Shaw MA, Silveira F, Shaw JJ, Jeronimo SM, Blackwell JM (2007) Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil. Genes Immun 8:84\u201390","journal-title":"Genes Immun"},{"key":"2130_CR36","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/0035-9203(94)90393-X","volume":"88","author":"SM Jeronimo","year":"1994","unstructured":"Jeronimo SM, Oliveira RM, Mackay S, Costa RM, Sweet J, Nascimento ET, Luz KG, Fernandes MZ, Jernigan J, Pearson RD (1994) An urban outbreak of visceral leishmaniasis in Natal. Brazil Trans R Soc Trop Med Hyg 88:386\u2013388","journal-title":"Brazil Trans R Soc Trop Med Hyg"},{"key":"2130_CR37","doi-asserted-by":"publisher","first-page":"e3198","DOI":"10.1371\/journal.pntd.0003198","volume":"8","author":"R Kumar","year":"2014","unstructured":"Kumar R, Singh N, Gautam S, Singh OP, Gidwani K, Rai M, Sacks D, Sundar S, Nylen S (2014) Leishmania specific CD4 T cells release IFNgamma that limits parasite replication in patients with visceral leishmaniasis. PLoS Negl Trop Dis 8:e3198. https:\/\/doi.org\/10.1371\/journal.pntd.0003198","journal-title":"PLoS Negl Trop Dis"},{"key":"2130_CR38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4269\/ajtmh.2001.65.87","volume":"65","author":"HA Lessa","year":"2001","unstructured":"Lessa HA, Machado P, Lima F, Cruz AA, Bacellar O, Guerreiro J, Carvalho EM (2001) Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg 65:87\u201389","journal-title":"Am J Trop Med Hyg"},{"key":"2130_CR39","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nmeth.1681","volume":"8","author":"C Lippert","year":"2011","unstructured":"Lippert C, Listgarten J, Liu Y, Kadie CM, Davidson RI, Heckerman D (2011) FaST linear mixed models for genome-wide association studies. Nat Methods 8:833\u2013835. https:\/\/doi.org\/10.1038\/nmeth.1681","journal-title":"Nat Methods"},{"key":"2130_CR40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/0035-9203(84)90043-9","volume":"78","author":"EA Llanos Cuentas","year":"1984","unstructured":"Llanos Cuentas EA, Cuba CC, Barreto AC, Marsden PD (1984) Clinical characteristics of human Leishmania braziliensis braziliensis infections. Trans R Soc Trop Med Hyg 78:845\u2013846. https:\/\/doi.org\/10.1016\/0035-9203(84)90043-9","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2130_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3947\/ic.2013.45.3.253","volume":"45","author":"M Loeb","year":"2013","unstructured":"Loeb M (2013) Host genomics in infectious diseases. Infect Chemother 45:253\u2013259. https:\/\/doi.org\/10.3947\/ic.2013.45.3.253","journal-title":"Infect Chemother"},{"key":"2130_CR42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1471-2350-12-162","volume":"12","author":"S Mehrotra","year":"2011","unstructured":"Mehrotra S, Fakiola M, Oommen J, Jamieson SE, Mishra A, Sudarshan M, Tiwary P, Rani DS, Thangaraj K, Rai M, Sundar S, Blackwell JM (2011) Genetic and functional evaluation of the role of CXCR1 and CXCR2 in susceptibility to visceral leishmaniasis in north-east India. BMC Med Genet 12:162. https:\/\/doi.org\/10.1186\/1471-2350-12-162","journal-title":"BMC Med Genet"},{"key":"2130_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/sj.ejhg.5201089","volume":"12","author":"HS Mohamed","year":"2004","unstructured":"Mohamed HS, Ibrahim ME, Miller EN, White JK, Cordell HJ, Howson JMM, Peacock CS, Khalil EAG, Elhassan AM, Blackwell JM (2004) SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in the Sudan. Eur J Hum Genet 12:66\u201374","journal-title":"Eur J Hum Genet"},{"key":"2130_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1017\/9781139680295.004","volume-title":"The genetics of african populations in health and disease","author":"HS Mohamed","year":"2019","unstructured":"Mohamed HS, Ibrahim ME, Blackwell JM (2019) 4. Genetic susceptibility to visceral leishmaniasis. In: Ibrahim ME, Rotimi CN (eds) The genetics of african populations in health and disease. Cambridge University Press, Cambridge, pp 71\u201385"},{"key":"2130_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1745-7580-6-9","volume":"6","author":"M Nielsen","year":"2010","unstructured":"Nielsen M, Justesen S, Lund O, Lundegaard C, Buus S (2010) NetMHCIIpan-2.0 improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res 6:9. https:\/\/doi.org\/10.1186\/1745-7580-6-9","journal-title":"Immunome Res"},{"key":"2130_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/jid.2014.305","volume":"135","author":"FO Novais","year":"2015","unstructured":"Novais FO, Carvalho LP, Passos S, Roos DS, Carvalho EM, Scott P, Beiting DP (2015) Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology. J Invest Dermatol 135:94\u2013101. https:\/\/doi.org\/10.1038\/jid.2014.305","journal-title":"J Invest Dermatol"},{"key":"2130_CR47","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","volume":"28","author":"S Nylen","year":"2007","unstructured":"Nylen S, Sacks D (2007) Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28:378\u2013384. https:\/\/doi.org\/10.1016\/j.it.2007.07.004","journal-title":"Trends Immunol"},{"key":"2130_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1084\/jem.20061141","volume":"204","author":"S Nylen","year":"2007","unstructured":"Nylen S, Maurya R, Eidsmo L, Manandhar KD, Sundar S, Sacks D (2007) Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 204:805\u2013817. https:\/\/doi.org\/10.1084\/jem.20061141","journal-title":"J Exp Med"},{"key":"2130_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cyto.2013.12.016","volume":"66","author":"WN Oliveira","year":"2014","unstructured":"Oliveira WN, Ribeiro LE, Schrieffer A, Machado P, Carvalho EM, Bacellar O (2014) The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis. Cytokine 66:127\u2013132. https:\/\/doi.org\/10.1016\/j.cyto.2013.12.016","journal-title":"Cytokine"},{"key":"2130_CR50","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/gepi.8","volume":"20","author":"CS Peacock","year":"2001","unstructured":"Peacock CS, Collins A, Shaw MA, Silveira F, Costa J, Coste CH, Nascimento MD, Siddiqui R, Shaw JJ, Blackwell JM (2001) Genetic epidemiology of visceral leishmaniasis in northeastern Brazil. Genet Epidemiol 20:383\u2013396","journal-title":"Genet Epidemiol"},{"key":"2130_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/gepi.20303","volume":"32","author":"I Pe'er","year":"2008","unstructured":"Pe'er I, Yelensky R, Altshuler D, Daly MJ (2008) Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol 32:381\u2013385. https:\/\/doi.org\/10.1002\/gepi.20303","journal-title":"Genet Epidemiol"},{"issue":"1229\u20131242","key":"2130_CR52","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.molcel.2019.06.025","volume":"75","author":"F Petermann","year":"2019","unstructured":"Petermann F, Pekowska A, Johnson CA, Jankovic D, Shih HY, Jiang K, Hudson WH, Brooks SR, Sun HW, Villarino AV, Yao C, Singleton K, Akondy RS, Kanno Y, Sher A, Casellas R, Ahmed R, O'Shea JJ (2019) The magnitude of IFN-gamma responses is fine-tuned by DNA architecture and the non-coding transcript of Ifng-as1. Mol Cell 75(1229\u20131242):e5. https:\/\/doi.org\/10.1016\/j.molcel.2019.06.025","journal-title":"Mol Cell"},{"key":"2130_CR53","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.meegid.2010.04.006","volume":"10","author":"R Ramasawmy","year":"2010","unstructured":"Ramasawmy R, Menezes E, Magalhaes A, Oliveira J, Castellucci L, Almeida R, Rosa ME, Guimaraes LH, Lessa M, Noronha E, Wilson ME, Jamieson SE, Kalil J, Blackwell JM, Carvalho EM, de Jesus AR (2010) The -2518bp promoter polymorphism at CCL2\/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. Infect Genet Evol 10:607\u2013613","journal-title":"Infect Genet Evol"},{"key":"2130_CR54","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","volume":"7","author":"R Reithinger","year":"2007","unstructured":"Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S (2007) Cutaneous leishmaniasis. Lancet Infect Dis 7:581\u2013596. https:\/\/doi.org\/10.1016\/S1473-3099(07)70209-8","journal-title":"Lancet Infect Dis"},{"key":"2130_CR55","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.4049\/jimmunol.180.9.6139","volume":"180","author":"A Salhi","year":"2008","unstructured":"Salhi A, Rodrigues V Jr, Santoro F, Dessein H, Romano A, Castellano LR, Sertorio M, Rafati S, Chevillard C, Prata A, Alcais A, Argiro L, Dessein A (2008) Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis. J Immunol 180:6139\u20136148","journal-title":"J Immunol"},{"key":"2130_CR56","first-page":"1159","volume":"57","author":"MA Shaw","year":"1995","unstructured":"Shaw MA, Davies CR, Llanos-Cuentas EA, Collins A (1995) Human genetic susceptibility and infection with Leishmania peruviana. Am J Hum Genet 57:1159\u20131168","journal-title":"Am J Hum Genet"},{"key":"2130_CR57","doi-asserted-by":"publisher","first-page":"e1874","DOI":"10.1371\/journal.pntd.0001874","volume":"6","author":"OP Singh","year":"2012","unstructured":"Singh OP, Stober CB, Singh AK, Blackwell JM, Sundar S (2012) Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis. PLoS Negl Trop Dis 6:e1874. https:\/\/doi.org\/10.1371\/journal.pntd.0001874","journal-title":"PLoS Negl Trop Dis"},{"key":"2130_CR58","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.4049\/jimmunol.1701764","volume":"200","author":"T Singh","year":"2018","unstructured":"Singh T, Fakiola M, Oommen J, Singh AP, Singh AK, Smith N, Chakravarty J, Sundar S, Blackwell JM (2018) Epitope-binding characteristics for risk versus protective DRB1 alleles for visceral leishmaniasis. J Immunol 200:2727\u20132737. https:\/\/doi.org\/10.4049\/jimmunol.1701764","journal-title":"J Immunol"},{"key":"2130_CR59","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/S0035-9203(01)90219-6","volume":"95","author":"EE Zijlstra","year":"2001","unstructured":"Zijlstra EE, El-Hassan AM (2001a) Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg 95:S59\u201376","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2130_CR60","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/S0035-9203(01)90218-4","volume":"95","author":"EE Zijlstra","year":"2001","unstructured":"Zijlstra EE, El-Hassan AM (2001b) Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg 95:S27\u2013S58","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2130_CR61","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4269\/ajtmh.1994.51.826","volume":"51","author":"EE Zijlstra","year":"1994","unstructured":"Zijlstra EE, El Hassan AM, Ismael A, Ghalib HW (1994) Endemic kala-azar in Eastern Sudan, a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg 51:826\u2013836","journal-title":"Am J Trop Med Hyg"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-020-02130-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00439-020-02130-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-020-02130-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:41:40Z","timestamp":1613090500000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00439-020-02130-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":61,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2130"],"URL":"https:\/\/doi.org\/10.1007\/s00439-020-02130-w","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]},"assertion":[{"value":"5 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}